findmyKOL

Seth Steinberg, PhD

Enriched profile

Retired (as of ~June 2025) from National Institutes of Health / National Cancer Institute; prior role held 23.5 years: Head, Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI · National Cancer Institute (NCI)

ORCID↗NPINone on file
RegionNot on fileSpecialtyHematology / OncologyFocusLymphoma Diagnosis and Treatment+4
Last active 2024Latest publication2024Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Seth Steinberg is Retired (as of ~June 2025) from National Institutes of Health / National Cancer Institute; prior role held 23.5 years: Head, Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, NCI at National Cancer Institute (NCI). OpenAlex indexes 1,645 publications with 87,905 citations (h-index 150).

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Seth M. Steinberg is Retired (as of ~June 2025) from National Institutes of Health / National Cancer Institute. The public record shows 1,645 publications with 87,905 citations (h-index 150), centered on Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses.

  • Most recent indexed publication: 2024 · Journal of clinical oncology
  • Top research focus: Lymphoma Diagnosis and Treatment

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Prostate CancerLymphomaSarcoma

Research focus

OpenAlex concept fingerprint
Lymphoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesSarcoma Diagnosis and TreatmentProstate Cancer Treatment and Research

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,645publications

Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.

87,905citations

Total citations across indexed works.

150h-index

Hirsch index (OpenAlex). i10-index 733.

Clinical & industry

trials, payments and federal funding
—clinical trials

Not shown. No U.S. clinical registration on file.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

15 more publications behind the reveal.Reveal →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Use of proteomic patterns in serum to identify ovarian cancer
    3,257 citations2002
    doi.org ↗
  2. 02
    T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
    2,938 citations2014
    doi.org ↗
  3. 03
    A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
    2,705 citations2003
    doi.org ↗
  4. 04
    Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
    2,122 citations2011
    doi.org ↗
  5. 05
    Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
    1,573 citations2003
    doi.org ↗
1,640 more cited works behind the reveal.Reveal →

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

William D. Figg270David J. Liewehr193Brigitte C. Widemann154
37 more collaborators behind the reveal.Reveal →

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/seth-steinberg-66237934

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Seth-Steinberg

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    grantome.com/grant/NIH/Z01-SC007202-24

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →grantome.com ↗
  • Other

    rocketreach.co/seth-steinberg-email_24480087

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rocketreach.co ↗
  • LinkedIn

    LinkedIn profile confirms retirement: "Seth Steinberg - Retired Biostatistician for National Cancer Institute"; independent second WebSearch synthesis corroborates 23.5 years of NIH service, a celebrated last day …

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • PhD

    Biostatistics, University of North Carolina at Chapel Hill

    1983
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Editorial & leadership roles

journal and society appointments
  • Head

    Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, NIH

    2025
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pub.orcid.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.